BE2016C049I2 - - Google Patents

Info

Publication number: BE2016C049I2
Authority: BE; Belgium
Prior art keywords: pharmaceutical composition; leishmaniasis; proteins; animal; prevention
Prior art date: 1998-12-23

Application number

BE2016C049C

Other languages

English (en)

Dutch (nl)

Original Assignee

Laboratorios Leti S L

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-23

Filing date

2016-10-06

Publication date

2019-03-05

1998-12-23 Priority claimed from CA2256124A external-priority patent/CA2256124C/en

2016-10-06 Application filed by Laboratorios Leti S L filed Critical Laboratorios Leti S L

2019-03-05 Publication of BE2016C049I2 publication Critical patent/BE2016C049I2/nl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Tropical Medicine & Parasitology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

BE2016C049C 1998-12-23 2016-10-06 BE2016C049I2 (sh)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US11382598P	1998-12-23	1998-12-23
CA2256124A CA2256124C (en)	1998-12-23	1998-12-23	Chimeric gene formed of the dna sequences that encode the antigenic determinants of four proteins of l. infantum, and protein encoded by said gene, and pharmaceutical composition useful for preventing and/or treating leishmaniosis in animals or humans
PCT/EP1999/010441 WO2000039298A1 (en)	1998-12-23	1999-12-23	Chimeric gene encoding the antigenic determinants of four proteins of l. infantum

Publications (1)

Publication Number	Publication Date
BE2016C049I2 true BE2016C049I2 (sh)	2019-03-05

Family

ID=25680668

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BE2016C049C BE2016C049I2 (sh)	1998-12-23	2016-10-06

Country Status (22)

Country	Link
EP (1)	EP1141305B1 (sh)
CN (1)	CN1158387C (sh)
AT (2)	ATE429498T1 (sh)
AU (1)	AU759316B2 (sh)
BE (1)	BE2016C049I2 (sh)
BG (1)	BG65569B1 (sh)
BR (1)	BRPI9916549B8 (sh)
CY (3)	CY1105331T1 (sh)
CZ (1)	CZ20012360A3 (sh)
DE (2)	DE69931518T2 (sh)
DK (1)	DK1141305T3 (sh)
ES (2)	ES2326174T3 (sh)
HR (1)	HRP20010554A2 (sh)
HU (1)	HUP0104743A3 (sh)
IL (2)	IL143956A0 (sh)
LU (1)	LU93259I2 (sh)
MX (1)	MXPA01006548A (sh)
NL (1)	NL300830I2 (sh)
PT (2)	PT1141305E (sh)
SI (1)	SI1624063T1 (sh)
TR (1)	TR200102655T2 (sh)
WO (1)	WO2000039298A1 (sh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6613337B1 (en) *	1997-02-12	2003-09-02	Corixa Corporation	Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
ES2169995B1 (es) *	2000-04-17	2003-12-01	Leti Lab	Composicion a base de la proteina lip2a y su uso en la preparacion de un medicamento para suscitar una respuesta inmune contra un antigeno.
US6673351B1 (en)	2001-03-16	2004-01-06	Astralis, Llc	Compositions and methods for the treatment and clinical remission of psoriasis
WO2006058243A2 (en) *	2004-11-24	2006-06-01	Yale University	Leishmania antigens and related compositions and uses
CA2712475A1 (en) *	2008-01-18	2009-07-23	Laboratorios Leti, S.L. Unipersonal	Vaccine comprising a ribosomal protein extract (rpe) and optionally a th1-promoting adjuvant
IN2012DN00401A (sh) *	2009-07-13	2015-08-21	Leti Sl Lab
SA110310855B1 (ar)	2009-11-13	2014-09-16	Laboratories Leti S L Unipersonal	استخدام مصدر l3 و/ أو l5 كلقاح أو كوسيلة تشخيصية لمرض طفيلي
BR102019003639A2 (pt) *	2019-02-22	2021-11-16	Fundação Oswaldo Cruz	Proteína quimérica, seu método para produção e uso, bem como molécula de ácido nucleico, cassete de expressão, vetor de expressão, célula hospedeira, composição para diagnóstico de leishmaniose, kit de diagnóstico de leishmaniose e método de diagnóstico de leishmaniose in vitro
ES2795149B2 (es)	2020-06-08	2022-07-04	Univ Madrid Complutense	Quimera sintetica multiepitopica como vacuna y tratamiento frente a leishmaniosis en mamiferos
CN112662694A (zh) *	2020-12-25	2021-04-16	康九生物科技(长春)有限公司	一种麦芽糖结合蛋白、麦芽糖结合蛋白表达载体、重组工程菌及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0703295A1 (en) *	1994-09-26	1996-03-27	Institut Pasteur	Vaccine composition comprising recombinant BCG expressing gp 63 fusion protein
US5912166A (en) *	1995-04-21	1999-06-15	Corixa Corporation	Compounds and methods for diagnosis of leishmaniasis
ES2133236B1 (es) *	1997-06-27	2000-04-16	Leti Lab	Gen quimerico formado por las secuencias de dna que codifican los determinantes antigenicos de cuatro proteinas de l. infantum, aplicable para el diagnostico serologico de leishmaniosis canina y proteina obtenida.

1999
- 1999-12-23 CN CNB998163066A patent/CN1158387C/zh not_active Expired - Lifetime
- 1999-12-23 DE DE69931518T patent/DE69931518T2/de not_active Expired - Lifetime
- 1999-12-23 AT AT05109393T patent/ATE429498T1/de not_active IP Right Cessation
- 1999-12-23 AU AU24342/00A patent/AU759316B2/en not_active Expired
- 1999-12-23 ES ES05109393T patent/ES2326174T3/es not_active Expired - Lifetime
- 1999-12-23 CZ CZ20012360A patent/CZ20012360A3/cs unknown
- 1999-12-23 SI SI9931029T patent/SI1624063T1/sl unknown
- 1999-12-23 DK DK99967987T patent/DK1141305T3/da active
- 1999-12-23 DE DE69940793T patent/DE69940793D1/de not_active Expired - Lifetime
- 1999-12-23 EP EP99967987A patent/EP1141305B1/en not_active Expired - Lifetime
- 1999-12-23 ES ES99967987T patent/ES2273519T3/es not_active Expired - Lifetime
- 1999-12-23 MX MXPA01006548A patent/MXPA01006548A/es active IP Right Grant
- 1999-12-23 TR TR2001/02655T patent/TR200102655T2/xx unknown
- 1999-12-23 PT PT99967987T patent/PT1141305E/pt unknown
- 1999-12-23 WO PCT/EP1999/010441 patent/WO2000039298A1/en active IP Right Grant
- 1999-12-23 BR BRPI9916549A patent/BRPI9916549B8/pt not_active IP Right Cessation
- 1999-12-23 HU HU0104743A patent/HUP0104743A3/hu unknown
- 1999-12-23 AT AT99967987T patent/ATE327332T1/de active
- 1999-12-23 PT PT05109393T patent/PT1624063E/pt unknown
- 1999-12-23 IL IL14395699A patent/IL143956A0/xx unknown
2001
- 2001-06-24 IL IL143956A patent/IL143956A/en not_active IP Right Cessation
- 2001-07-23 HR HR20010554A patent/HRP20010554A2/hr not_active Application Discontinuation
- 2001-07-23 BG BG105725A patent/BG65569B1/bg unknown
2006
- 2006-08-24 CY CY20061101190T patent/CY1105331T1/el unknown
2009
- 2009-07-14 CY CY20091100739T patent/CY1109221T1/el unknown
2016
- 2016-09-22 NL NL300830C patent/NL300830I2/nl unknown
- 2016-10-06 LU LU93259C patent/LU93259I2/fr unknown
- 2016-10-06 BE BE2016C049C patent/BE2016C049I2/nl unknown
- 2016-10-20 CY CY2016033C patent/CY2016033I1/el unknown

Also Published As

Publication number	Publication date
CY2016033I2 (el)	2017-03-15
DE69931518T2 (de)	2006-12-21
AU759316B2 (en)	2003-04-10
PT1141305E (pt)	2006-10-31
ES2273519T3 (es)	2007-05-01
BG65569B1 (bg)	2008-12-30
CN1335889A (zh)	2002-02-13
NL300830I1 (nl)	2016-09-28
CY2016033I1 (el)	2017-03-15
BRPI9916549B8 (pt)	2022-08-30
CY1105331T1 (el)	2010-03-03
IL143956A0 (en)	2002-04-21
EP1141305A1 (en)	2001-10-10
BR9916549A (pt)	2005-01-04
HRP20010554A2 (en)	2002-08-31
LU93259I2 (fr)	2016-12-06
DE69931518D1 (de)	2006-06-29
MXPA01006548A (es)	2003-03-27
TR200102655T2 (tr)	2002-04-22
WO2000039298A1 (en)	2000-07-06
ES2326174T3 (es)	2009-10-02
BG105725A (en)	2002-06-28
CN1158387C (zh)	2004-07-21
HUP0104743A2 (hu)	2002-03-28
DK1141305T3 (da)	2006-09-25
BRPI9916549B1 (pt)	2018-10-02
ATE327332T1 (de)	2006-06-15
CY1109221T1 (el)	2014-07-02
PT1624063E (pt)	2009-06-19
EP1141305B1 (en)	2006-05-24
DE69940793D1 (de)	2009-06-04
AU2434200A (en)	2000-07-31
HUP0104743A3 (en)	2004-10-28
ATE429498T1 (de)	2009-05-15
CZ20012360A3 (cs)	2001-10-17
SI1624063T1 (sl)	2009-08-31
NL300830I2 (nl)	2020-08-31
IL143956A (en)	2010-11-30

Publication	Publication Date	Title
BE2016C049I2 (sh)	2019-03-05
PT910647E (pt)	2008-04-15	Variantes hiperactivas da dnase i humana
WO2000053758A3 (en)	2001-02-08	Compositions and methods for the treatment of immune related diseases
DE69636760D1 (de)	2007-01-25	Rekombinanter anti-cd4 antikörper zur menschlichen behandlung
PT2009025E (pt)	2011-09-19	Método de inibição da actividade dos osteoclastos
HK1043937A1 (zh)	2002-10-04	Bpi蛋白質產品的人類醫療用途
BG104266A (en)	2000-11-30	Aminoterminally incised mcp-2 as haemokin antagonists
YU79202A (sh)	2006-01-16	Peptid koji modulira trombopoetinski receptor
WO1999014241A3 (en)	1999-06-10	Compositions and methods for the treatment of immune related diseases
BG105275A (en)	2001-11-30	Tan-1057 derivatives
ATE310828T1 (de)	2005-12-15	Implantat und vektor zur behandlung von erworbenen krankheiten
WO2001095946A3 (en)	2002-09-06	Combination product for carrying out a cytotoxic treatment in a mammal
MXPA04001986A (es)	2004-06-07	Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad.
YU51601A (sh)	2005-07-19	Himerni gen koji kodira antigene determinante četiri proteina l.infantum
WO2001040465A3 (en)	2002-03-21	Compositions and methods for the treatment of immune related diseases
PL336897A1 (en)	2000-07-17	Novel salts of bpc peptides, pharmaceutic compositions conatining them and method of obtaining such salts
DE59410423D1 (de)	2006-01-12	Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
WO2000015797A3 (en)	2000-08-24	Compositions and methods for the treatment of immune related diseases
WO2001066740A3 (en)	2002-09-19	Compositions and methods for the treatment of immune related diseases
WO2001016319A3 (en)	2001-10-04	Compositions and methods for the treatment of immune related diseases
AU7043301A (en)	2001-11-20	A novel polypeptide, a human protein 9 containing a fragment of p5cr specific sequence
DE60143025D1 (de)	2010-10-21	Zusammensetzung zur behandlung von periodontalen erkrankungen
EP1624063A3 (en)	2006-07-05	Chimeric gene encoding the antigenic determinants of four proteins of L. infantum
MX9800686A (es)	1998-10-31	Nueva proteina hmw humana mp52s.
EP1529842A3 (en)	2005-06-08	Compositions and methods for the treatment of immune related diseases